Water Immersion in Chronic Stable Heart Failure (IMMERSE-HF)

Water Immersion and Water-based Exercise in Patients With Chronic Stable Heart Failure: A Pilot Study

This study aims to investigate the effects of water immersion and exercise on heart function and blood flow in patients with chronic stable heart failure.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

27

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cottingham, United Kingdom, HU165JQ
        • Castle Hill Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age >18
  • Established diagnosis of heart failure with NTpro BNP >100

Exclusion Criteria:

  • Uncontrolled or severe heart failure, defined by NYHA class IV symptoms (breathlessness at rest)
  • Severe fluid overload characterised as more than minimal pitting oedema of the ankles only
  • Presence of haemodynamically significant valvular heart disease in the opinion of the investigator
  • Haemoglobin <125 g/L
  • Weight >120 kilograms
  • Requiring long term oxygen supplementation in the community
  • Hospitalisation for any cause within the last 6 weeks, that in the opinion of the investigator would affect the patients wellbeing in this study
  • Unstable or severe stable angina that requires three or more antianginals
  • Patients known to have disease causing immunocompromise such as HIV infection or undergoing chemotherapy
  • Patients with active infection
  • Dialysis patients
  • Uncontrolled seizures; patients in whom the pool environment may trigger seizures, new diagnosis of epilepsy
  • Insulin treated diabetic patients with hypoglycaemic episodes in the last 3 months.
  • Pregnant women
  • Central venous lines which are not tunnelled and are exposed superficially.
  • Open access ports to lungs including tracheotomy sites
  • Ventilation tubes for ears
  • Nasogastric or gastrostomy tube in situ
  • Presence of colostomy, ileostomy or urostomy.
  • Presence of open, macerated, infected or non-intact skin or oedema with leakage of serous fluid.
  • Skin condition such as severe eczema or psoriasis
  • Any surgery or invasive devices fitted within the last 4 weeks
  • Any form of mobility impairment requiring mobility aids (e.g. stick or wheelchair) or rendering patient unable to perform gentle exercises, including recent injury or trauma
  • History of chlorine sensitivity
  • Urinary or faecal incontinence
  • Hydrophobia
  • Unable to give consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: water immersion
patients with heart failure will be immersed to the neck for 15 minutes
warm water immersion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Cardiac output
Time Frame: 15 minutes of water immersion
15 minutes of water immersion

Secondary Outcome Measures

Outcome Measure
Time Frame
Heart rate (beats/minute)
Time Frame: 15 minutes of water immersion
15 minutes of water immersion
Blood pressure (mmHg)
Time Frame: 15 minutes of water immersion
15 minutes of water immersion
systemic vascular resistance (dyn·s/cm5)
Time Frame: 15 minutes of water immersion
15 minutes of water immersion
Stroke volume (millilitres)
Time Frame: 15 minutes of water immersion
15 minutes of water immersion
Jugular venous pressure (not raised, raised 1-4cm, raised to earlobes, undetectable)
Time Frame: 15 minutes of water immersion
15 minutes of water immersion
BORG dyspnoea score (score between 1-10)
Time Frame: 15 minutes of water immersion
15 minutes of water immersion
cardiac output (milliliters/minute)
Time Frame: 3 minutes of exercise in water
3 minutes of exercise in water
N-terminal pro b-type natriuretic peptide (ng/L)
Time Frame: 10 mins after water immersion
10 mins after water immersion
Left ventricular end systolic diameter (mm)
Time Frame: 15 minutes of water immersion
15 minutes of water immersion
Left ventricular end diastolic diameters (mm)
Time Frame: 15 minutes of water immersion
15 minutes of water immersion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrew Clark, Castle Hill Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 22, 2016

Primary Completion (ACTUAL)

April 4, 2017

Study Completion (ACTUAL)

April 4, 2017

Study Registration Dates

First Submitted

October 13, 2016

First Submitted That Met QC Criteria

October 28, 2016

First Posted (ESTIMATE)

October 31, 2016

Study Record Updates

Last Update Posted (ACTUAL)

June 19, 2019

Last Update Submitted That Met QC Criteria

June 17, 2019

Last Verified

June 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • R1996

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on water immersion

Subscribe